Cita APA (7a ed.)

Hansen, A. R., Borgwardt, L., Rasmussen, Å. K., Godballe, C., Godballe, C., Poulsen, M. M., . . . Rossing, M. (2021). Germline RET Leu56Met Variant Is Likely Not Causative of Multiple Endocrine Neoplasia Type 2. Frontiers Media S.A.

Cita Chicago Style (17a ed.)

Hansen, Anna Reimer, et al. Germline RET Leu56Met Variant Is Likely Not Causative of Multiple Endocrine Neoplasia Type 2. Frontiers Media S.A, 2021.

Cita MLA (8a ed.)

Hansen, Anna Reimer, et al. Germline RET Leu56Met Variant Is Likely Not Causative of Multiple Endocrine Neoplasia Type 2. Frontiers Media S.A, 2021.